Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein (MAP) kinases are proline-directed serine/threonine kinases that are activated by dual phosphorylation on threonine and tyrosine residues in response to a wide array of extracellular stimuli. Three distinct groups of MAP kinases have been identified in mammalian cells [extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38]. These MAP kinases are mediators of signal transduction from the cell surface to the nucleus. One nuclear target of these MAP kinase signaling pathways is the transcription factor AP-1. MAP kinases regulate AP-1 transcriptional activity by multiple mechanisms. Here we review recent progress towards understanding AP-1 regulation by the ERK, JNK, and p38 MAP kinase signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“c-Jun forms homodimers or can heterodimerize with other Jun family members or with other bZIP proteins including members of the Fos and ATF/cAMP response element-binding protein (CREB) families (18,19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“The c-Jun promoter contains important TPA response elements that preferentially bind heterodimers of c-Jun and ATF-2, both of which are activated upon phosphorylation by JNK (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes (17)(18)(19).”
From c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor (1999) · cites this paper as [18]
In the citing paper
“Usually, c-Jun forms heterodimers with c-Fos in AP-1 transcription factor complexes [69, 70].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [70]
Citations
Cites
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Self-citationMarshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Self-citationIntegrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,937
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J.-D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,646
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Self-citation
Cited by
Items 201–300 of 1,001
Regulation of innate immune response by MAP kinase phosphatase-1
Wang, X., & Liu, Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.03.013 · Cited by 153
MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?
Clark, A. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780005 · Cited by 147
Ogasawara, A., Arakawa, T., Kaneda, T., Takuma, T., Sato, T., Kaneko, H., Kumegawa, M., & Hakeda, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008070200 · Cited by 166
Monje, P., Marinissen, M. J., & Gutkind, J. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.7030-7043.2003 · Cited by 147
“These results indicated that the ERK pathway regulates the expression of c-fos (38, 47) as well as the posttranslational events occurring on the newly synthesized c-Fos molecules in response to PDGF.”
BackgroundRui, T., Feng, Q., Lei, M.-P., Peng, T., ZHANG, J., Xu, M., Abel, E. D., Xenocostas, A., & Kvietys, P. R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.019 · Cited by 150
“Targeted disruption of the AP-1 components is either lethal at the embryonic stage (cjun) or the mice are viable, but display morphological abnormalities (c-fos) [29].”
BackgroundAbderrahmani, A., Niederhäuser, G., Favre, D., Abdelli, S., Ferdaoussi, M., Yang, J. Y., Regazzi, R., Widmann, C., & Waeber, G. (2007) · Diabetologia · doi:10.1007/s00125-007-0642-z · Cited by 158
“AP1 activity and c-Jun expression are induced by an unusually broad range of environmental stressors [44].”
Role and regulation of activator protein-1 in toxicant-induced responses of the lung
Reddy, S. P. M., & Mossman, B. T. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00140.2002 · Cited by 147
“The activated JNKs bind to the docking site located in the NH2-terminal region of c-Jun and phosphorylate Ser63 and -73 located within its transactivation domain (145).”
BackgroundInfluentialPoulsen, L. K., Jacobsen, N., Sørensen, B. B., Bergenhem, N. C. H., Kelly, J. D., Foster, D. C., Thastrup, O., Ezban, M., & Petersen, L. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6228 · Cited by 149
Mediators of Physical Activity Protection against ROS-Linked Skeletal Muscle Damage
Di Meo, S., Napolitano, G., & Venditti, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123024 · Cited by 145
“Activation of ERK1/2 regulates the transcriptional activity of activator protein-1 (AP-1) [172], avian myelocytomatosis virus oncogene cellular homolog (c-Myc) and the cell survival protein B-cell lymphoma-2 (Bcl-2) [173].”
BackgroundInfluentialc-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Have Distinct Roles in CD8+ T Cell Activation
Conze, D., Krahl, T., Kennedy, N., Weiss, L., Lumsden, J., Hess, P., Flavell, R. A., Le Gros, G., Davis, R. J., & Rincón, M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011508 · Cited by 146
Self-citationSubbaramaiah, K., Cole, P. A., & Dannenberg, A. J. (2002) · PubMed · Cited by 157
Kundu, J. K., & Surh, Y. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.04.019 · Cited by 160
Jorritsma, P. J., Brogdon, J. L., & Bottomly, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2427 · Cited by 143
Regulation of human airway epithelial cell IL-8 expression by MAP kinases
Li, J., Kartha, S., Iasvovskaia, S., Tan, A., Bhat, R. K., Manaligod, J. M., Page, K., Brasier, A. R., & Hershenson, M. B. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00060.2002 · Cited by 157
“Activation of MAP kinases, which may translocate from the cytoplasm to the nucleus after mitogenic stimulation, has been shown to induce phosphorylation and increase the trans-activating activity of a number of nuclear transcription factors, including the AP-1 transcription factors c-Fos and c-Jun (4, 18, 29, 35, 67,…”
BackgroundPuls, A., Eliopoulos, A. G., Nobes, C. D., Bridges, T., Young, L. S., & Hall, A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.17.2983 · Cited by 145
Xi, X.-P., Graf, K., Goetze, S., Fleck, E., Hsueh, W. A., & Law, R. E. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.73 · Cited by 142
Activation of cJUN N-Terminal Kinase by Herpes Simplex Virus Type 1 Enhances Viral Replication
McLean, T. I., & Bachenheimer, S. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8415-8426.1999 · Cited by 146
“JNK1-3 (cJUN N-terminal kinase) and p38, sometimes collectively referred to as SAPKs, are the MAPKs for these pathways, and corresponding MAPKKs and MAPKKKs have been characterized that specifically activate JNKs and/or p38 (40, 52, 92).”
BackgroundInfluentialCell fate decision: T-helper 1 and 2 subsets in immune responses.
Dong, C., & Flavell, R. A. (2000) · Arthritis Research · doi:10.1186/ar85 · Cited by 154
Upregulation of MMP‐9 production by TNFα in keratinocytes and its attenuation by vitamin D
Bahar‐Shany, K., Ravid, A., & Koren, R. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.22004 · Cited by 156
“The involvement of JNK and p38 MAPK in the regulation of MMP-9 gene expression The two members of the MAPK family, JNK and p38, were mentioned as modulators of MMPs expression in various experimental systems (Liang et al., 2007) and are known to induce components of the AP-1 transcription factor complex.”
BackgroundInfluentialHuang, C., Ma, W., Hanenberger, D., Cleary, M. P., Bowden, G. T., & Dong, Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26325 · Cited by 150
PARP-1 activation in the ERK signaling pathway
COHENARMON, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.08.005 · Cited by 137
Fujisawa, T., Joshi, B. H., & Puri, R. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.26366 · Cited by 135
“We further investigated whether MAPK pathway is also activated by IL-13 after its binding with IL-13Ra2 because AP-1 transcription factor is regulated by MAPK.26 We found that IL-13 treatment resulted in activation of ERK, which is known to be an important key players of MAPK pathway.27 Further, we observed that AP-1,…”
BackgroundInfluentialLin, Y.-W., & Yang, J.-L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508720200 · Cited by 137
Hashimoto, S., Gon, Y., Takeshita, I., Matsumoto, K., Jibiki, I., Takizawa, H., Kudoh, S., & Horie, T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9904110 · Cited by 139
Adinolfi, E., Pizzirani, C., Idzko, M., Panther, E., Norgauer, J., Di Virgilio, F., & Ferrari, D. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-6322-x · Cited by 136
“They also activate transcription factors, triggering expression of early response genes coding for growth-promoting proteins [ 108 ].”
BackgroundThe Role of Schwann Cell-Axon Interaction in Peripheral Nerve Regeneration
Namgung, U. (2014) · Cells Tissues Organs · doi:10.1159/000370324 · Cited by 135
Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease
Wancket, L. M., Frazier, W. J., & Liu, Y. (2012) · Life Sciences · doi:10.1016/j.lfs.2011.11.017 · Cited by 135
“MAPKs can also enhance the activities of numerous transcription factors, including AP-1 (Whitmarsh and Davis, 1996), CREB (Arthur and Cohen, 2000; Arthur et al., 2004; Eliopoulos et al., 2002; Wong et al., 2004), SRF (Posern and Treisman, 2006), and C/EBPβ (Davis, 1993).”
BackgroundInfluentialSamra, Y. A., Said, H. S., Elsherbiny, N. M., Liou, G. I., El‐Shishtawy, M. M., & Eissa, L. A. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.002 · Cited by 139
Lin, Y.-W., Chuang, S.-M., & Yang, J.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301854200 · Cited by 136
Svegliati-Baroni, G., Ridolfi, F., Di Sario, A., Saccomanno, S., Bendia, E., Benedetti, A., & Greenwel, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23788 · Cited by 134
Strukova, S. M. (2006) · Frontiers in bioscience · doi:10.2741/1780 · Cited by 136
Immediate early response genes and cell transformation
Healy, S., Khan, P., & Davie, J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.001 · Cited by 162
Halls, M. L., Bathgate, R. A. D., Sutton, S. W., Dschietzig, T. B., & Summers, R. J. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009472 · Cited by 143
“Many MAPK signaling pathways [p38 MAPK (Roux and Blenis, 2004); JNK (Davis, 2000); and ERK1/2 (Price et al., 1996; Whitmarsh and Davis, 1996)] converge on AP-1 elements to increase gene transcription, therefore AP-1-linked reporter genes together with selective inhibitors provide useful information on signaling in dif…”
InfluentialMedeiros, R., Otuki, M. F., Avellar, M. C. W., & Calixto, J. Β. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.005 · Cited by 132
Hwang, Y. P., Oh, K. N., Yun, H. J., & Jeong, H. G. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.10.016 · Cited by 136
Oldenhof, A. D., Shynlova, O. P., Liu, M., Langille, B. L., & Lye, S. J. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00607.2001 · Cited by 132
“In addition to activating Elk-1, JNK and p38 can phosphorylate ATF-2, which can promote transcription of the c-fos gene at the cAMP response element (CRE) (45).”
InfluentialChen, W., Dong, Z., Valcic, S., Timmermann, B. N., & Bowden, G. T. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199902)24:2<79::aid-mc1>3.0.co;2-e · Cited by 132
Uzzo, R. G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl034 · Cited by 131
Peroxynitrite signaling: receptor tyrosine kinases and activation of stress-responsive pathways
Klotz, L., Schröeder, P., & Sies, H. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00892-4 · Cited by 146
Young, M. R., Nair, R., Bucheimer, N., Tulsian, P., Brown, N., Chapp, C., Hsu, T.-C., & Colburn, N. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.587-598.2002 · Cited by 131
“Among ERK’s major nuclear targets are the ternary complex factor (TCF), Elk-1, and Sap-1a (33, 39, 49, 67).”
BackgroundSignal Transduction Pathways in Hyperoxia-Induced Lung Cell Death
Mantell, L. L., & Lee, P. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3046 · Cited by 130
Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
Guo, X., Ma, N., Wang, J., Song, J., Bu, X., Cheng, Y., Sun, K., Xiong, H., Jiang, G., Zhang, B., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-375 · Cited by 130
“Regulation of the AP-1 pathway is highly complex and activation of certain signal pathways seems to stimulate the transcriptional activity of AP-1 [12].”
BackgroundSchieke, S. M., Briviba, K., Klotz, L.-O., & Sies, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00372-5 · Cited by 130
Schlesinger, T. K., Fanger, G. R., Yujiri, T., & Johnson, G. L. (1998) · Frontiers in bioscience · doi:10.2741/a354 · Cited by 139
“In the cytoplasm, ERK1/2 have also been shown to regulate a number of kinases including the EGF receptor, Raf1 and MEK, decreasing their catalytic activities in a possible feedback regulatory loop (24).”
BackgroundMitochondria‐Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury
Kezic, A., Spasojevic, I., Lezaic, V., & Bajcetic, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2950503 · Cited by 129
“Recently, novel therapeutic approach called ischemic preconditioning has become translated from animal models to humans [20, 21].”
BackgroundAntioxidant Properties of Plant-Derived Phenolic Compounds and Their Effect on Skin Fibroblast Cells
Merecz-Sadowska, A., Sitarek, P., Kucharska, E., Kowalczyk, T., Zajdel, K., Cegliński, T., & Zajdel, R. (2021) · Antioxidants · doi:10.3390/antiox10050726 · Cited by 151
“JNK, p38, and ERK1/2 are types of MAPKs and belong to the serine/threonine kinase family involved in the transmission of external stimuli into the cell nucleus [71,72].”
BackgroundSecor, P. R., James, G. A., Fleckman, P. H., Olerud, J. E., McInnerney, K., & Stewart, P. S. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-143 · Cited by 151
“NFkB and AP-1 are activated by pro-inflammatory cytokines such as TNFa and IL-1b which act through MAPK-dependent signal cascades resulting in the production of additional cytokines [ 35-38 ].”
BackgroundWang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128
“34 and apoptosis caused by osmotic shock or ultraviolet irradiation”
BackgroundKim, G., Kim, J., Ahn, S., Lee, H., Moon, D., Lee, C., & Park, Y. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01945.x · Cited by 126
Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallate
Chen, L., & Zhang, H. (2007) · Molecules · doi:10.3390/12050946 · Cited by 127
The human cathelicidin hCAP18/LL-37: A multifunctional peptide involved in mycobacterial infections
Méndez‐Samperio, P. (2010) · Peptides · doi:10.1016/j.peptides.2010.06.016 · Cited by 140
Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Funaki, M., Inukai, K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101087200 · Cited by 127
Brownell, J., Bruckner, J. J., Wagoner, J., Thomas, E., Loo, Y., Gale, M., Liang, T. J., & Polyak, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.02007-13 · Cited by 143
Chen, C.-C., Chow, M.-P., Huang, W.-C., Lin, Y.-C., & Chang, Y.-J. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05652-9 · Cited by 125
“Activation of ERK results in an increase in AP-1 activity via c-fos induction, whereas JNK activation leads to the c-jun phosphorylation (Karin, 1995; Whitmarsh and Davis, 1996).”
Topical glucocorticoids and the skin‐mechanisms of action: an update
Ahluwalia, A. (1998) · Mediators of Inflammation · doi:10.1080/09629359891126 · Cited by 141
“These factors regulate the expression of inflammatory cytokines and adhesion molecules and indeed inhibition of the activity of these transcription factors has profound effects on inflammatory and immune responses.(31,32) Whilst it seems clear that the GC-R complex binds directly with AP-1, thereby blocking AP-1-depen…”
BackgroundMitogen-activated protein (MAP) kinase pathways in plants: Versatile signaling tools
Ligterink, W., & Hirt, H. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)01004-x · Cited by 133
Thuerauf, D. J., Arnold, N. D., Zechner, D., Hanford, D. S., DeMartin, K. M., McDonough, P. M., Prywes, R., & Glembotski, C. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20636 · Cited by 122
Chun, K.-S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh076 · Cited by 121
From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling
Morinville, A., Maysinger, D., & Shaver, A. G. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01257-7 · Cited by 143
Temkin, V., Kantor, B., Weg, V., Hartman, M.-L., & Levi-Schaffer, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2662 · Cited by 120
Silvers, A. L., Bachelor, M. A., & Bowden, G. T. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80025-8 · Cited by 120
“with the SRE to influence c-fos expression [30].”
BackgroundInfluentialC-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma.
Yang, Y.-M., Bost, F., Charbono, W., Dean, N. S., McKay, R. A., Rhim, J. S., Depatie, C., & Mercola, D. (2003) · PubMed · Cited by 130
Guo, Y.-S., Hellmich, M. R., Wen, X. D., & Townsend, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101801200 · Cited by 120
Merecz-Sadowska, A., Sitarek, P., Kowalczyk, T., Zajdel, K., Jęcek, M., Nowak, P. A., & Zajdel, R. (2023) · Nutrients · doi:10.3390/nu15133016 · Cited by 143
“AP-1 can also bind promoters of inflammatory mediators independently of NF-κB during inflammation [95,96].”
Backgroundα1-Adrenergic signaling mechanisms in contraction of resistance arteries
Wier, W. G., & Morgan, K. G. (2003) · Springer eBooks · doi:10.1007/s10254-003-0019-8 · Cited by 121
Ferrer, I., Fríguls, B., Dalfó, E., & Planas, A. M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0661-2 · Cited by 131
“The JNKs are activated by phosphorylation through JNK kinases (JNKKs), also called MAP kinase kinases (MKKs) [39, 59, 96 , 100].”
InfluentialEicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts
Kim, H. H., Shin, C. M., Park, C.-H., Kim, K. H., Cho, K. H., Eun, H. C., & Chung, J. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500105-jlr200 · Cited by 119
“family members (21, 22), we investigated the effects of EPA on UV-induced c-Jun phosphorylation/expression and c-Fos”
BackgroundRegulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases
Wang, S., Nath, N., Minden, A., & Chellappan, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1559 · Cited by 133
“p38 kinase was immunoprecipitated from the same extracts and used in an in vitro kinase assay using GST–ATF2 as a substrate (Xia et al., 1995; Whitmarsh and Davis, 1996).”
Methodp38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle
Meloche, S., Landry, J., Huot, J., Houle, F., Marceau, F., & Giasson, E. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.2.h741 · Cited by 129
“The samples were analyzed by SDS gel electrophoresis, and the band corresponding to GST-ATF2 was excised and counted.”
BackgroundInfluentialTranscription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease
Jundi, K., & Greene, C. M. (2015) · Biomolecules · doi:10.3390/biom5031386 · Cited by 122
“In contrast to NF- B which normally resides in the cytosol but translocates to the nucleus when I B is released, AP-1 is directly bound to its target sequence on DNA and its trans-activating activity is regulated by its abundance, phosphorylation of transactivation domains, and the binding of protein kinases [22].”
Kar, S., Subbaram, S., Carrico, P. M., & Melendez, J. A. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.019 · Cited by 139
Kida, Y., SHIMIZU, T., & Kuwano, K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.014 · Cited by 130
Stocco, C. O., Lau, L. F., & Gibori, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110936200 · Cited by 118
1,25-Dihydroxyvitamin D3 Stimulates Activator Protein-1-dependent Caco-2 Cell Differentiation
Chen, A., Davis, B. H., Bissonnette, M., Scaglione-Sewell, B., & Brasitus, T. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35505 · Cited by 126
PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes
Li, R. C. X., Ping, P., Zhang, J., Wead, W. B., Cao, X., Gao, J., Zheng, Y., Huang, S., Han, J., & Bolli, R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1679 · Cited by 118
“In noncardiac cells, it has been shown that p44/p42 MAPKs activate AP-1, Elk-1, and NF-kB (7, 8, 18, 44, 53) and that p54/p46 JNKs activate AP-1 (18, 44, 47).”
BackgroundEnvironmental factors as regulators and effectors of multistep carcinogenesis
Minamoto, T., Mai, M., & Ronai, Z. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.4.519 · Cited by 142
Molecular mechanisms of nitrogen dioxide induced epithelial injury in the lung
Persinger, R. L., Poynter, M. E., Ckless, K., & Janssen-Heininger, Y. M. W. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015973530559 · Cited by 129
“JNK can also bind and phosphorylate other transcription factors in the activator protein-1 (AP-1) family, such as ATF-2, JunB, and Jun D [67, 76 ].”
BackgroundStein, C. B., Field, A. R., Mimoso, C. A., Zhao, C., Huang, K.-L., Wagner, E. J., & Adelman, K. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.10.004 · Cited by 120
Ochratoxin A Induces JNK Activation and Apoptosis in MDCK-C7 Cells at Nanomolar Concentrations
Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., Wilflingseder, D., Pollack, V., Dander, M., & Schramek, H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39305-x · Cited by 132
Ahn, J. D., Morishita, R., Kaneda, Y., Lee, S., Kwon, K.-Y., Choi, S., Lee, K.-U., Park, J., Moon, I.-J., Park, J.-G., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000023200.19316.d5 · Cited by 116
Protective Role for c-Jun in the Cellular Response to DNA Damage
Potapova, O., Basu, S., Mercola, D., & Holbrook, N. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102075200 · Cited by 117
Page, K., Strunk, V. S., & Hershenson, M. B. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.050 · Cited by 116
A central control for cell growth
Whitmarsh, A. J., & Davis, R. J. (2000) · Nature · doi:10.1038/35002220 · Cited by 129
Self-citationMAP kinase signaling cascades and gene expression in osteoblasts
Hipskind, R. A., & Bilbe, G. (1998) · Frontiers in bioscience · doi:10.2741/a323 · Cited by 120
“They are induced by a wide range of cellular stresses (among them UV irradiation, chemical, oxidative, hypoxia and anoxia, heat shock, protein synthesis inhibitors, inflammatory cytokines), but also by a wide range of stimuli, including cytokines and G-protein-coupled receptors among others (25, 50).”
BackgroundInfluentialInterleukin-1β costimulates interferon-γ production by human natural killer cells
Cooper, M. A., Fehniger, T. A., Ponnappan, A., Mehta, V. B., Wewers, M. D., & Caligiuri, M. A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200103)31:3<792::aid-immu792>3.0.co;2-u · Cited by 145
Involvement of oxidative stress in 4-vinylcyclohexene-induced toxicity in Drosophila melanogaster
Abolaji, A. O., Kamdem, J. P., Lugokenski, T. H., Gonzaga, T. K. S. D. N., Waczuk, E. P., Farombi, E. O., Loreto, É. L. S., & da Rocha, J. B. T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.014 · Cited by 120
Bui, C., Barter, M. J., Scott, J. L., Xu, Y., Galler, M., Reynard, L. N., Rowan, A. D., & Young, D. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-206367 · Cited by 125
Papachristou, D. J., Batistatou, A. K., Sykiotis, G. P., Varakis, I., & Papavassiliou, A. G. (2003) · Bone · doi:10.1016/s8756-3282(03)00026-7 · Cited by 112
“The c-Jun N-terminal kinase (JNK) signal transduction pathway is involved in malignant cellular transformation [4].”
BackgroundInfluentialUtsugi, M., Dobashi, K., Ishizuka, T., Endou, K., Hamuro, J., Murata, Y., Nakazawa, T., & Mori, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.628 · Cited by 112
Suominen, P., Möttönen, T., Rajamäki, A., & Irjala, K. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1016::aid-anr9>3.0.co;2-3 · Cited by 90
MicroRNA regulation of innate immune responses in epithelial cells
Zhou, R., O’Hara, S. P., & Chen, X. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.19 · Cited by 120
“The activator protein 1 (AP-1) transcription factor is composed of heterodimers of the c-Fos and c-Jun families and can be activated through different MAPK pathways”
BackgroundZhao, D., Keates, A. C., Kuhnt-Moore, S., Moyer, M. P., Kelly, C. P., & Pothoulakis, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104942200 · Cited by 111
Milde-Langosch, K., Bamberger, A.-M., Rieck, G., Grund, D., Hemminger, G., Müller, V, & Löning, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602655 · Cited by 110
“…of the AP-1 family, which include members of the Jun family (c-Jun, JunB, JunD) and Fos family (c-Fos, FosB, Fra-1 and Fra-2) have been identified as targets of MAP kinases (Whitmarsh and Davis, 1996). c-Jun and JunB are phosphorylated by the Jun N-terminal kinase JNK (MechtaGrigoriou et al, 2001).”
BackgroundXie, J., Pan, H., Yoo, S., & Gao, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15027-15037.2005 · Cited by 122
“MAPK pathways, which have important roles in a broad spectrum of cellular functions, including cell proliferation, differentiation, survival, death, and gene expression, mediate AP-1 activation (35, 56, 65).”
BackgroundLee, J., Kim, J., Park, J. K., Chung, G., & Jang, Y. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00410-5 · Cited by 109
Mutual regulation of c‐Jun and ATF2 by transcriptional activation and subcellular localization
Liu, H., Deng, X., Shyu, Y. J., Li, J. J., Taparowsky, E. J., & Hu, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601020 · Cited by 132
“…on c-Jun and ATF2 is required for the activation of c-Jun and ATF2 The EMBO Journal VOL 25 | NO 5 | 2006 &2006 European Molecular Biology Organization1060 (Whitmarsh and Davis, 1996; Karin et al, 1997), we examined the impact of phosphorylation on the dimerization and nuclear localization of ATF2.”
BackgroundInfluentialGenome-scale functional profiling of the mammalian AP-1 signaling pathway
Chanda, S. K., White, S. M., Orth, A. P., Reisdorph, R. M., Miraglia, L. J., Thomas, R. S., DeJesus, P., Mason, D. E., Huang, Q., Vega, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934839100 · Cited by 113
Algate, K., Haynes, D. R., Bartold, P. M., Crotti, T. N., & Cantley, M. D. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12339 · Cited by 123
Salvatore, M. F., Zhang, J., Large, D. M., Wilson, P. E., Gash, C. R., Thomas, T. C., Haycock, J. W., Bing, G., Stanford, J. A., Gash, D. M., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02496.x · Cited by 108
A human brain tumor-derived PDGFR-α deletion mutant is transforming
Clarke, I. D., & Dirks, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206160 · Cited by 124
“…signal transduction, we performed an assay for c-Jun activation in PDGFR-a and PDGFR-aD8,9 transfected NIH 3T3 cells. c-Jun is a component of the AP-1 complex and its activation has been implicated in oncogenic transformation (Whitmarsh and Davis, 1996; Ip and Davis, 1998; Vogt, 2001).”
Method
Metadata
- Authors
- Whitmarsh, A. J., & Davis, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Molecular Medicine
- Published
- 1996-10
- Volume
- 74
- Issue
- 10
- Pages
- 589-607
- ISSN
- 0946-2716 (ISSN-L)
- OpenAlex
- W2031272027
- Cited by
- 1,543
- References
- 207
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 27 · 2019: 20 · 2018: 28 · 2017: 29 · 2016: 29 · 2015: 39 · 2014: 34 · 2013: 40 · 2012: 37
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AP-1 transcription factor, mitogen-activated protein kinase, ERK, c-Jun N-terminal kinase, p38 MAPK, MAPK signaling, transcriptional regulation, dual phosphorylation, signal transduction
- MeSH terms
- Animals, Humans, Mammals, Signal Transduction, Calcium-Calmodulin-Dependent Protein Kinases, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.